Connexin 43 Modulation in Human Chondrocytes, Osteoblasts and Cartilage Explants: Implications for Inflammatory Joint Disorders
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158547 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Elena Della Morte und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biotechnological Applications, IRCCS Istituto Ortopedico Galeazzi, 20157 Milan, Italy. Hauptthemen laut MEDLINE: Connexin 43, Chondrocytes, Osteoblasts, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Connexin 43 (Cx43) is crucial for the development and homeostasis of the musculoskeletal system, where it plays multifaceted roles, including intercellular communication, transcriptional regulation and influencing osteogenesis and chondrogenesis. Here, we investigated Cx43 modulation mediated by inflammatory stimuli involved in osteoarthritis, i.e., 10 ng/mL Tumor Necrosis Factor alpha (TNFα) and/or 1 ng/mL Interleukin-1 beta (IL-1β), in primary chondrocytes (CH) and osteoblasts (OB). Additionally, we explored the impact of synovial fluids from osteoarthritis patients in CH and cartilage explants, providing a more physio-pathological context. The effect of TNFα on Cx43 expression in cartilage explants was also assessed. TNFα downregulated Cx43 levels both in CH and OB (−73% and −32%, respectively), while IL-1β showed inconclusive effects. The reduction in Cx43 levels was associated with a significant downregulation of the coding gene GJA1 expression in OB only (−65%). The engagement of proteasome in TNFα-induced effects, already known in CH, was also observed in OB. TNFα treatment significantly decreased Cx43 expression also in cartilage explants. Of note, Cx43 expression was halved by synovial fluid in both CH and cartilage explants. This study unveils the regulation of Cx43 in diverse musculoskeletal cell types under various stimuli and in different contexts, providing insights into its modulation in inflammatory joint disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Biotechnological Applications, IRCCS Istituto Ortopedico Galeazzi, 20157 Milan, Italy.
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, 20129 Milan, Italy.
- Hip Department, IRCCS Istituto Ortopedico Galeazzi, 20157 Milan, Italy.
ORCID-Profile: Elena Della Morte, Chiara Giannasi, Francesca Cadelano, Stefania Niada, Anna Teresa Brini
Förderung
- Italian Ministry of Health
Zitieren
APA
Della Morte, E., Giannasi, C., Valenza, A., Cadelano, F., Aldegheri, A., Zagra, L., Niada, S., & Brini, A. T. (2024). Connexin 43 Modulation in Human Chondrocytes, Osteoblasts and Cartilage Explants: Implications for Inflammatory Joint Disorders. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158547
Vancouver
Della Morte E, Giannasi C, Valenza A, Cadelano F, Aldegheri A, Zagra L, et al. Connexin 43 Modulation in Human Chondrocytes, Osteoblasts and Cartilage Explants: Implications for Inflammatory Joint Disorders. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158547
BibTeX
@article{DellaMorte2024,
author = {Della Morte, Elena and Giannasi, Chiara and Valenza, Alice and Cadelano, Francesca and Aldegheri, Alessandro and Zagra, Luigi and Niada, Stefania and Brini, Anna Teresa},
title = {Connexin 43 Modulation in Human Chondrocytes, Osteoblasts and Cartilage Explants: Implications for Inflammatory Joint Disorders},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158547}
}
EUVIMED